Berjame, Angelita R.
HRN: 17-64-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/03/2023
MUPIROCIN 2%, 15G (TUBE)
10/03/2023
10/09/2023
TOPICAL
Apply On Affected Areas
Bid
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes